Taurine (generic name)

treats Vaccine adjunct, Obesity, Vision problems, Congestive heart failure, Nutritional support, Myotonic dystrophy, Diabetes mellitus, Iron de...
Table of Contents
powered by healthline

Average Ratings


This information is based on a systematic review of scientific literature, and was peer-reviewed and edited by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com): Julie Conquer, PhD (RGB Consulting); Tracee Abrams, PharmD (University of Rhode Island); Nicole Giese, MS (Natural Standard Research Collaboration); Juliann Goodfriend, PharmD (Northeastern University); Toni Schaeffer, PhD, PharmD (Albany College of Pharmacy); Rebecca Strauss, PharmD (Northeastern University); Shaina Tanguay-Colucci, BS (Natural Standard Research Collaboration); Wendy Weissner, BA (Natural Standard Research Collaboration); Mario M. Zeolla, PharmD, BCPS (Albany College of Pharmacy).


DISCLAIMER: Natural Standard developed the above evidence-based information based on a thorough systematic review of the available scientific articles. For comprehensive information about alternative and complementary therapies on the professional level, go to www.naturalstandard.com. Selected references are listed below.

Azuma J, Sawamura A, Awata N, et al. Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. Clin.Cardiol. 1985;8(5):276-282.

Balkan J, Oztezcan S, Hatipoglu A, et al. Effect of a taurine treatment on the regression of existing atherosclerotic lesions in rabbits fed on a high-cholesterol diet. Biosci Biotechnol Biochem 2004;68(5):1035-1039.

Colombo C, Battezzati PM, Podda M, et al. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. Hepatology 1996;23(6):1484-1490.

Hagar HH, El Etter E, Arafa M. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats. Clin Exp Pharmacol Physiol 2006;33(3):189-196.

Li Q, Guo JC, Jin HB, et al. Involvement of taurine in penicillin-induced epilepsy and anti-convulsion of acupuncture: a preliminary report. Acupunct Electrother Res 2005;30(1-2):1-14.

Mas MR, Isik AT, Yamanel L, et al. Antioxidant treatment with taurine ameliorates chronic pancreatitis in an experimental rat model. Pancreas 2006;33(1):77-81.

Merli M, Bertasi S, Servi R, et al. Effect of a medium dose of ursodeoxycholic acid with or without taurine supplementation on the nutritional status of patients with cystic fibrosis: a randomized, placebo-controlled, crossover trial. J.Pediatr.Gastroenterol.Nutr. 1994;19(2):198-203.

Oriyanhan W, Yamazaki K, Miwa S, et al. Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation. Heart Vessels 2005;20(6):278-285.

Rakotoambinina B, Marks L, Badran AM, et al. Taurine kinetics assessed using [1,2-13C2]taurine in healthy adult humans. Am.J.Physiol Endocrinol.Metab 2004;287(2):E255-E262.

Smith LJ, Lacaille F, Lepage G, et al. Taurine decreases fecal fatty acid and sterol excretion in cystic fibrosis. A randomized double-blind trial. Am.J.Dis.Child 1991;145(12):1401-1404.

Spencer AU, Yu S, Tracy TF, et al. Parenteral nutrition-associated cholestasis in neonates: multivariate analysis of the potential protective effect of taurine. JPEN J Parenter.Enteral Nutr 2005;29(5):337-343.

Spohr C, Brons C, Winther K, et al. No effect of taurine on platelet aggregation in men with a predisposition to type 2 diabetes mellitus. Platelets. 2005;16(5):301-305.

Tabassum H, Rehman H, Banerjee BD, et al. Attenuation of tamoxifen-induced hepatotoxicity by taurine in mice. Clin Chim.Acta 2006;370(1-2):129-136.

Tyson JE, Lasky R, Flood D, et al. Randomized trial of taurine supplementation for infants less than or equal to 1,300-gram birth weight: effect on auditory brainstem-evoked responses. Pediatrics 1989;83(3):406-415.

Zhang M, Bi LF, Fang JH, et al. Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino.Acids 2004;26(3):267-271.

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Page: < Back 1 2 3 4
Licensed from
Top of page
General Drug Tools
General Drug Tools
Health Management
Health Management Programs
Tools for
Healthy Living
Tools for Healthy Living